NAOV nanovibronix.com: שווי החברה בספרים

NanoVibronix, Inc. (NAOV) management is developing portable tissue regeneration solutions, aiming to expand insurance coverage and sales within medical centers. This price chart reflects a current level of 0.05. The business relies on surface acoustic wave technology to combat infections, generating revenue through UroShield consumables. Steady demand for patches and international distribution support the company's operating profitability.

The complex cross-border logistics of components for NanoVibronix, Inc. (NAOV) require significant resources; therefore, an analysis of the balance sheet capitalization allows for an assessment of the real value of net assets minus all liabilities. This metric reflects the business's internal capital, confirming the company's financial stability and its ability to maintain sales margins while diversifying contractors, which minimizes the risk of overpaying for the asset.